LYMPH-TARGETING FORMULATIONS
The present invention relates to pharmaceutical formulations comprising a lipase inhibitor and long-chain fatty acids. The formulation enables the lipase inhibitor to be delivered to the intestinal lymph and are thereby useful in the treatment or prevention of diseases and conditions mediated by pan...
Gespeichert in:
Hauptverfasser: | , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | PHILLIPS, Anthony HAN, Sifei LU, Zijun HONG, Jiwon STYLES, Ian Kenneth TREVASKIS, Natalie LEE, Given WINDSOR, John PORTER, Christopher John |
description | The present invention relates to pharmaceutical formulations comprising a lipase inhibitor and long-chain fatty acids. The formulation enables the lipase inhibitor to be delivered to the intestinal lymph and are thereby useful in the treatment or prevention of diseases and conditions mediated by pancreatic lipase, such as acute pancreatitis and associated syndromes.
La présente invention concerne des formulations pharmaceutiques comprenant un inhibiteur de lipase et des acides gras à longue chaîne. La formulation permet à l'inhibiteur de lipase d'être administré dans la lymphe intestinale et est ainsi utile dans le traitement ou la prévention de maladies et d'états pathologiques médiés par la lipase pancréatique, tels que la pancréatite aiguë et les syndromes associés. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2022087659A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2022087659A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2022087659A13</originalsourceid><addsrcrecordid>eNrjZJDxifQN8NANcQxydw3x9HNXcPMP8g31cQzx9PcL5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgZGRgYW5mamlo6GxsSpAgAbYCIk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>LYMPH-TARGETING FORMULATIONS</title><source>esp@cenet</source><creator>PHILLIPS, Anthony ; HAN, Sifei ; LU, Zijun ; HONG, Jiwon ; STYLES, Ian Kenneth ; TREVASKIS, Natalie ; LEE, Given ; WINDSOR, John ; PORTER, Christopher John</creator><creatorcontrib>PHILLIPS, Anthony ; HAN, Sifei ; LU, Zijun ; HONG, Jiwon ; STYLES, Ian Kenneth ; TREVASKIS, Natalie ; LEE, Given ; WINDSOR, John ; PORTER, Christopher John</creatorcontrib><description>The present invention relates to pharmaceutical formulations comprising a lipase inhibitor and long-chain fatty acids. The formulation enables the lipase inhibitor to be delivered to the intestinal lymph and are thereby useful in the treatment or prevention of diseases and conditions mediated by pancreatic lipase, such as acute pancreatitis and associated syndromes.
La présente invention concerne des formulations pharmaceutiques comprenant un inhibiteur de lipase et des acides gras à longue chaîne. La formulation permet à l'inhibiteur de lipase d'être administré dans la lymphe intestinale et est ainsi utile dans le traitement ou la prévention de maladies et d'états pathologiques médiés par la lipase pancréatique, tels que la pancréatite aiguë et les syndromes associés.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220505&DB=EPODOC&CC=WO&NR=2022087659A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220505&DB=EPODOC&CC=WO&NR=2022087659A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PHILLIPS, Anthony</creatorcontrib><creatorcontrib>HAN, Sifei</creatorcontrib><creatorcontrib>LU, Zijun</creatorcontrib><creatorcontrib>HONG, Jiwon</creatorcontrib><creatorcontrib>STYLES, Ian Kenneth</creatorcontrib><creatorcontrib>TREVASKIS, Natalie</creatorcontrib><creatorcontrib>LEE, Given</creatorcontrib><creatorcontrib>WINDSOR, John</creatorcontrib><creatorcontrib>PORTER, Christopher John</creatorcontrib><title>LYMPH-TARGETING FORMULATIONS</title><description>The present invention relates to pharmaceutical formulations comprising a lipase inhibitor and long-chain fatty acids. The formulation enables the lipase inhibitor to be delivered to the intestinal lymph and are thereby useful in the treatment or prevention of diseases and conditions mediated by pancreatic lipase, such as acute pancreatitis and associated syndromes.
La présente invention concerne des formulations pharmaceutiques comprenant un inhibiteur de lipase et des acides gras à longue chaîne. La formulation permet à l'inhibiteur de lipase d'être administré dans la lymphe intestinale et est ainsi utile dans le traitement ou la prévention de maladies et d'états pathologiques médiés par la lipase pancréatique, tels que la pancréatite aiguë et les syndromes associés.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJDxifQN8NANcQxydw3x9HNXcPMP8g31cQzx9PcL5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgZGRgYW5mamlo6GxsSpAgAbYCIk</recordid><startdate>20220505</startdate><enddate>20220505</enddate><creator>PHILLIPS, Anthony</creator><creator>HAN, Sifei</creator><creator>LU, Zijun</creator><creator>HONG, Jiwon</creator><creator>STYLES, Ian Kenneth</creator><creator>TREVASKIS, Natalie</creator><creator>LEE, Given</creator><creator>WINDSOR, John</creator><creator>PORTER, Christopher John</creator><scope>EVB</scope></search><sort><creationdate>20220505</creationdate><title>LYMPH-TARGETING FORMULATIONS</title><author>PHILLIPS, Anthony ; HAN, Sifei ; LU, Zijun ; HONG, Jiwon ; STYLES, Ian Kenneth ; TREVASKIS, Natalie ; LEE, Given ; WINDSOR, John ; PORTER, Christopher John</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2022087659A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2022</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>PHILLIPS, Anthony</creatorcontrib><creatorcontrib>HAN, Sifei</creatorcontrib><creatorcontrib>LU, Zijun</creatorcontrib><creatorcontrib>HONG, Jiwon</creatorcontrib><creatorcontrib>STYLES, Ian Kenneth</creatorcontrib><creatorcontrib>TREVASKIS, Natalie</creatorcontrib><creatorcontrib>LEE, Given</creatorcontrib><creatorcontrib>WINDSOR, John</creatorcontrib><creatorcontrib>PORTER, Christopher John</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PHILLIPS, Anthony</au><au>HAN, Sifei</au><au>LU, Zijun</au><au>HONG, Jiwon</au><au>STYLES, Ian Kenneth</au><au>TREVASKIS, Natalie</au><au>LEE, Given</au><au>WINDSOR, John</au><au>PORTER, Christopher John</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>LYMPH-TARGETING FORMULATIONS</title><date>2022-05-05</date><risdate>2022</risdate><abstract>The present invention relates to pharmaceutical formulations comprising a lipase inhibitor and long-chain fatty acids. The formulation enables the lipase inhibitor to be delivered to the intestinal lymph and are thereby useful in the treatment or prevention of diseases and conditions mediated by pancreatic lipase, such as acute pancreatitis and associated syndromes.
La présente invention concerne des formulations pharmaceutiques comprenant un inhibiteur de lipase et des acides gras à longue chaîne. La formulation permet à l'inhibiteur de lipase d'être administré dans la lymphe intestinale et est ainsi utile dans le traitement ou la prévention de maladies et d'états pathologiques médiés par la lipase pancréatique, tels que la pancréatite aiguë et les syndromes associés.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; fre |
recordid | cdi_epo_espacenet_WO2022087659A1 |
source | esp@cenet |
subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | LYMPH-TARGETING FORMULATIONS |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T17%3A19%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PHILLIPS,%20Anthony&rft.date=2022-05-05&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2022087659A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |